Evidence map›Paper›PMID 26379970›Full record

ArticleInternational journal of clinical and experimental medicine2015

A comparison on the prevalence and outcomes of gestational versus type 2 diabetes mellitus in 1718 Saudi pregnancies.

Amal Al Serehi, Amjad M Ahmed, Farah Shakeel, Khadija Alkhatani, Nahid K El-Bakri, Badr Aldin M Buhari, Uhoud Al Mohareb, Naji Aljohani

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Amal Al SerehiDepartment of Maternal-Fetal Medicine, King Fahad Medical City Riyadh 59046, Saudi Arabia.
Amjad M AhmedWomen's Specialized Hospital, Riyadh, King Fahad Medical City Riyadh 59046, Saudi Arabia.
Farah ShakeelPrince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia.
Khadija AlkhataniPrince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia.
Nahid K El-BakriResearch Center of Medicine, King Saud Bin Abdulaziz University for Health Sciences Riyadh 22490, Saudi Arabia.
Badr Aldin M BuhariResearch Center of Medicine, King Saud Bin Abdulaziz University for Health Sciences Riyadh 22490, Saudi Arabia.
Uhoud Al MoharebResearch Center of Medicine, King Saud Bin Abdulaziz University for Health Sciences Riyadh 22490, Saudi Arabia.
Naji AljohaniResearch Center of Medicine, King Saud Bin Abdulaziz University for Health Sciences Riyadh 22490, Saudi Arabia ; Specialized Diabetes and Endocrine Center, King Fahad Medical City Riyadh 59046, Saudi Arabia ; Prince Mutaib Chair for Biomarkers of Osteoporosis, College of Science, King Saud University Riyadh 11451, Saudi Arabia.
King Saud bin Abdulaziz University for Health Sciences · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of either diabetes mellitus type 2 (DMT2) or GDM constitute a high-risk pregnancy. Given the high rate of DMT2 and GDM in the kingdom of Saudi Arabia (KSA), no study has ever compared whether GDM outcomes are comparable to those with DMT2. The present study aims to compare for the first time, maternal and neonatal outcomes among Saudi patients with GDM, DMT2 and non-DM groups. This is a retrospective study covering data from 1718 pregnant patients admitted at King Fahad Medical City, Riyadh, KSA from April 2011 to March 2013. The prevalence of GDM was 13.8%, DMT2 was 0.9%. DMT2 group had the highest mean parity and shortest mean gestational age as compared to other groups. Half of all the subjects in the DMT2 group also experienced preterm labor, as opposed to only 10% in GDM and 14% in the non-DM group, respectively. Finally, neonates delivered by DMT2 mothers had the highest percentage of admissions to NICU (33%) as compared to 10% in the non-DM group and only 5% in the GDM group. Outcomes of the GDM group are almost comparable with the non-DM group. While the results of the present study reflect the efficient management of GDM cases in Saudi patients, DMT2 complicated pregnancies, which are considered to be at a much higher risk for maternal and neonatal complications, should be given equally special attention.

Indexed as

Gestational diabetesSauditype 2 diabetes mellitus

Identifiers

PMID26379970
PMCPMC4565353
OpenAlexW2237021178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.